TherapeuticsMD traded at $9.90 this Friday June 24th, decreasing $0.06 or 0.60 percent since the previous trading session. Looking back, over the last four weeks, TherapeuticsMD lost 354.13 percent. Over the last 12 months, its price rose by 725.00 percent. Looking ahead, we forecast TherapeuticsMD to be priced at 9.62 by the end of this quarter and at 8.87 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
9.90
Daily Change
-0.60%
Yearly
725.00%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 152.34 2.89 1.93% 34.84%
Agile Therapeutics 1.15 -0.05 -4.17% -14.81%
Novo Nordisk A Fs 112.12 3.69 3.40% 35.41%
Pfizer 51.59 1.50 2.99% 32.35%
Spectrum Pharmaceuticals 0.88 -0.01 -1.18% -77.38%
TherapeuticsMD 9.90 -0.06 -0.60% 725.00%

Indexes Price Day Year
US2000 1766 54.06 3.16% -24.36%

TherapeuticsMD
TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products from pregnancy prevention through menopause. Its product pipeline includes IMVEXXY, BIJUVA, ANNOVERA, and prenatal vitamin product. The IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy due to menopause. Its BIJUVA (estradiol and progesterone) capsules is a bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. Its ANNOVERA (segesterone acetate (SA) and ethinyl estradiol (EE) vaginal system) is a one-year ring-shaped contraceptive vaginal system (CVS) and patient-controlled, procedure-free, reversible prescription contraceptive. Its prenatal vitamin products are sold under vitaMedMD and BocaGreenMD brands.